Filing Details
- Accession Number:
- 0000937556-15-000061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-01 16:19:53
- Reporting Period:
- 2015-03-30
- Filing Date:
- 2015-04-01
- Accepted Time:
- 2015-04-01 16:19:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1403402 | Rick Fishel | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Pres, Ww Oem Bus & Blood Mgmt | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-30 | 12,500 | $3.33 | 64,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-03-30 | 12,500 | $32.85 | 52,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2015-03-30 | 12,500 | $0.00 | 12,500 | $3.33 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
33,940 | 2006-04-14 | 2015-04-14 | No | 4 | M | Direct |
Footnotes
- The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of June 13, 2014, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- This option was granted on April 4, 2005 and was exercisable as the option vested. This option vested over a five-year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.